Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Healthy Extracts (HYEX) Cost of Revenue (2016 - 2025)

Healthy Extracts filings provide 11 years of Cost of Revenue readings, the most recent being $736658.0 for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 106.48% to $736658.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.1 million, a 73.84% increase, with the full-year FY2025 number at $2.1 million, up 73.84% from a year prior.
  • Cost of Revenue hit $736658.0 in Q4 2025 for Healthy Extracts, up from $470725.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $736658.0 in Q4 2025 to a low of $34572.0 in Q2 2021.
  • Median Cost of Revenue over the past 5 years was $291921.5 (2023), compared with a mean of $294762.6.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 1936.36% in 2021 and later tumbled 78.37% in 2023.
  • Healthy Extracts' Cost of Revenue stood at $623248.0 in 2021, then dropped by 23.44% to $477163.0 in 2022, then tumbled by 78.37% to $103230.0 in 2023, then soared by 245.61% to $356774.0 in 2024, then soared by 106.48% to $736658.0 in 2025.
  • The last three reported values for Cost of Revenue were $736658.0 (Q4 2025), $470725.0 (Q3 2025), and $375828.0 (Q2 2025) per Business Quant data.